» Articles » PMID: 32876842

Telomere Length: How the Length Makes a Difference

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2020 Sep 3
PMID 32876842
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Telomerase is perceived as an immortality enzyme that might provide longevity to cells and whole organisms. Importantly, it is generally inactive in most somatic cells of healthy, adult men. Consequently, its substrates, i.e. telomeres, get shorter in most human cells with time. Noteworthy, cell life limitation due to telomere attrition during cell divisions, may not be as bad as it looks since longer cell life means longer exposition to harmful factors. Consequently, telomere length (attrition rate) becomes a factor that is responsible for inducing the signaling that leads to the elimination of cells that lived long enough to acquire severe damage. It seems that telomere length that depends on many different factors (including telomerase activity but also genetic factors, a hormonal profile that reflects sex, etc.) might become a useful marker of aging and exposition to stress. Thus in the current paper, we review the factors that affect telomere length in human cells focusing on sex that all together with different environmental and hormonal regulations as well as parental aspect affect telomere attrition rate. We also raise some limitations in the assessment of telomere length that hinders a trustworthy meta-analysis that might lead to acknowledgment of the real value of this parameter.

Citing Articles

Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).

Andreikos D, Spandidos D, Georgakopoulou V Int J Oncol. 2025; 66(3).

PMID: 39981889 PMC: 11844339. DOI: 10.3892/ijo.2025.5729.


Integrating the metabolic and molecular circuits in diabetes, obesity and cancer: a comprehensive review.

Anand S, Patel T Discov Oncol. 2024; 15(1):779.

PMID: 39692821 PMC: 11655924. DOI: 10.1007/s12672-024-01662-1.


Beginning at the ends: telomere and telomere-based cancer therapeutics.

Sadr Z, Ghasemi M, Jafarpour S, Seyfi R, Ghasemi A, Boustanipour E Mol Genet Genomics. 2024; 300(1):1.

PMID: 39638969 DOI: 10.1007/s00438-024-02206-6.


Altered Mitochondrial DNA Copy Number and Telomere Length in Patients with Substance Use Disorder: Correlation with Age, Sex, and Chronic Diseases.

Taseva T, Koycheva Y, Racheva R, Raycheva T, Hodzhev Y, Nikolova E Biochem Genet. 2024; .

PMID: 39614920 DOI: 10.1007/s10528-024-10981-5.


Causal relationship between leukocyte telomere length and two cardiomyopathies based on a bidirectional Mendelian randomization approach.

Li J, Hu L, Huang X Medicine (Baltimore). 2024; 103(45):e40308.

PMID: 39533571 PMC: 11556983. DOI: 10.1097/MD.0000000000040308.


References
1.
Titorenko V . Molecular and Cellular Mechanisms of Aging and Age-related Disorders. Int J Mol Sci. 2018; 19(7). PMC: 6073633. DOI: 10.3390/ijms19072049. View

2.
Zeng S, Shen W, Liu L . Senescence and Cancer. Cancer Transl Med. 2019; 4(3):70-74. PMC: 6372122. DOI: 10.4103/ctm.ctm_22_18. View

3.
Itahana K, Campisi J, Dimri G . Mechanisms of cellular senescence in human and mouse cells. Biogerontology. 2004; 5(1):1-10. DOI: 10.1023/b:bgen.0000017682.96395.10. View

4.
Xia X, Chen W, McDermott J, Han J . Molecular and phenotypic biomarkers of aging. F1000Res. 2017; 6:860. PMC: 5473407. DOI: 10.12688/f1000research.10692.1. View

5.
Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View